Complete Filing Data
ASP Isotopes Inc. reported Net Income Loss of -$32.42 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean ASP Isotopes Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Net Income * | -$32.4M | -$16.3M | -$4.9M |
| Cost of Revenue * | $2.5M | $294.1K | $0.00 |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$1.2M | -$1.2M | $236.3K |
| Operating Income Loss | -$26.4M | -$16.0M | -$5.1M |
| Operating Expenses | $28.0M | $16.2M | $5.1M |
| General And Administrative Expense | $24.8M | $15.4M | $3.8M |
| Research And Development Expense | $3.1M | $764.6K | $1.3M |
| Comprehensive Income Net Of Tax | -$33.5M | -$17.5M | -$4.7M |
| Nonoperating Income Expense | -$6.0M | -$258.3K | $153.9K |
| Income Tax Expense Benefit | $111.4K | -$6.1K | $0.00 |
| Revenues | $4.1M | $433.0K | $0.00 |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$32.3M | -$16.3M | -$4.9M |
| Gross Profit | $1.6M | $139.0K | $0.00 |
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | -$119.4K | $27.3K | -$4.7M |
| Net Income Loss From Continuing Operations Available To Common Shareholders Basic | -$32.3M | -$16.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$12.9M | -$75.2M | -$8.5M | -$7.4M | -$8.9M | -$7.0M | -$4.2M | -$4.3M | -$3.6M | -$2.0M | -$827.2K | -$857.6K | -$2.6M | -$508.2K | |
| Cost of Revenue * | $4.5M | $626.2K | $774.8K | $793.7K | $601.3K | $561.5K | $0.00 | $0.00 | $0.00 | ||||||
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | $959.2K | $1.0M | $1.2M | $1.3M | $763.4K | -$543.7K | -$64.6K | -$472.7K | -$1.0M | $150.5K | $354.5K | -$229.3K | |||
| Operating Income Loss | -$15.0M | -$12.0M | -$8.0M | -$5.4M | -$7.5M | -$5.8M | -$3.9M | -$4.3M | -$3.7M | -$2.0M | -$828.0K | -$858.3K | -$2.6M | -$508.2K | |
| Operating Expenses | $15.4M | $12.5M | $8.3M | $5.7M | $7.9M | $6.1M | $3.9M | $4.3M | $3.7M | $2.0M | $828.0K | $858.3K | $2.6M | $508.2K | |
| General And Administrative Expense | $12.3M | $11.7M | $6.7M | $4.7M | $7.4M | $5.9M | $3.7M | $4.1M | $3.5M | $1.2M | $674.6K | $565.2K | $2.6M | $508.2K | |
| Research And Development Expense | $3.1M | $879.9K | $1.5M | $1.0M | $473.3K | $215.1K | $239.2K | $252.9K | $207.3K | $745.5K | $153.4K | $293.1K | $41.6K | ||
| Comprehensive Income Net Of Tax | -$12.1M | -$74.1M | -$7.3M | -$6.0M | -$8.2M | -$7.5M | -$4.3M | -$4.8M | -$4.6M | -$1.8M | -$472.6K | -$1.1M | -$2.6M | -$519.3K | |
| Nonoperating Income Expense | $2.1M | -$63.1M | -$579.8K | -$1.9M | -$1.4M | -$1.2M | -$276.0K | $61.2K | $109.7K | -$2.5K | $789.00 | $665.00 | $115.00 | ||
| Income Tax Expense Benefit | $73.6K | $95.2K | -$70.7K | -$8.4K | $13.8K | -$47.6K | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Revenues | $4.9M | $1.2M | $1.1M | $1.1M | $1.0M | $840.4K | $0.00 | $0.00 | $0.00 | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$12.8M | -$75.1M | -$8.5M | -$7.4M | -$8.9M | -$7.0M | -$4.2M | -$4.3M | -$3.6M | ||||||
| Gross Profit | $423.2K | $572.1K | $326.8K | $294.0K | $421.0K | $278.9K | $0.00 | $0.00 | $0.00 | ||||||
| Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest | $150.9K | $1.5K | -$1.5K | -$18.4K | $52.3K | -$7.5K | $0.00 | $0.00 | $0.00 | ||||||
| Net Income Loss From Continuing Operations Available To Common Shareholders Basic | -$12.9M | -$75.1M | -$7.3M | -$8.9M | -$6.9M | -$4.2M | -$4.3M | -$3.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Stockholders Equity * | $16.3M | $9.8M | $0.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.4M | $3.0M | ||
| Operating Lease Right Of Use Asset | $1.3M | $853.9K | $933.1K | |
| Accounts Payable Current | $1.1M | $1.4M | $59.7K | |
| Retained Earnings Accumulated Deficit | -$23.8M | -$7.6M | -$2.6M | |
| Property Plant And Equipment Net | $10.7M | $8.2M | $3.0M | |
| Prepaid Expense And Other Assets Current | $1.7M | $913.0K | $267.6K | |
| Operating Lease Liability Noncurrent | $1.1M | $742.4K | $841.6K | |
| Operating Lease Liability Current | $336.6K | $45.9K | $38.1K | |
| Liabilities Current | $5.7M | $1.9M | $303.4K | |
| Liabilities And Stockholders Equity | $27.5M | $12.5M | $7.1M | |
| Liabilities | $8.7M | $2.7M | $1.1M | |
| Common Stock Value | $489.2K | $359.1K | $206.5K | |
| Assets Current | $10.5M | $3.3M | $3.2M | |
| Assets | $27.5M | $12.5M | $7.1M | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$921.0K | $255.0K | $18.7K | |
| Accrued Liabilities Current | $1.3M | $361.2K | $42.5K | |
| Other Assets Noncurrent | $1.8M | $139.6K | $0.00 | |
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | |
| Notes Payable Current | $470.4K | $33.9K | $46.9K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $54.5M | $5.5M | -$772.0K | |
| Repayments Of Notes Payable | $561.2K | $87.7K | $13.0K | |
| Goodwill | $3.2M | $0.00 | ||
| Gain Loss Change In Fair Value Of Share Liability | -$132.3K | -$194.5K | ||
| Gain Loss Change In Fair Value Of Convertible Notes Payable | -$6.9M | $0.00 | ||
| Change In Fair Value Of Share Liability | -$194.5K | $150.5K | ||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $364.5K | $70.6K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $74.1M | $25.2M | $42.5M | $47.9M | $38.7M | $11.0M | $10.5M | $18.8M | $8.6M | $10.2M | $11.9M | $6.3M | $7.4M | $7.0M | $6.0M | $2.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $113.9M | $67.7M | $56.0M | $61.9M | $51.6M | $28.3M | $23.9M | $7.9M | $2.3M | $3.6M | $5.1M | $431.6K | $2.8M | $3.8M | $1.9M | |
| Operating Lease Right Of Use Asset | $971.7K | $1.0M | $1.0M | $1.1M | $1.4M | $1.4M | $1.5M | $622.2K | $642.4K | $696.4K | $874.0K | $952.5K | ||||
| Accounts Payable Current | $3.4M | $2.6M | $2.0M | $1.0M | $1.8M | $2.4M | $2.2M | $402.0K | $670.1K | $1.3M | $1.2M | |||||
| Retained Earnings Accumulated Deficit | -$152.6M | -$139.7M | -$64.6M | -$56.2M | -$47.0M | -$39.7M | -$30.8M | -$19.7M | -$15.5M | -$11.2M | -$6.2M | |||||
| Property Plant And Equipment Net | $30.9M | $27.6M | $25.4M | $22.4M | $23.0M | $17.8M | $14.4M | $8.3M | $7.7M | $8.0M | $6.9M | |||||
| Prepaid Expense And Other Assets Current | $10.1M | $1.8M | $2.0M | $3.1M | $3.9M | $3.2M | $1.9M | $441.8K | $404.4K | $688.3K | $605.2K | |||||
| Operating Lease Liability Noncurrent | $618.0K | $639.4K | $569.9K | $688.5K | $912.5K | $1.0M | $1.1M | $630.3K | $648.2K | $698.0K | $710.8K | |||||
| Operating Lease Liability Current | $468.6K | $500.9K | $576.9K | $557.7K | $589.5K | $541.8K | $504.4K | $49.0K | $46.6K | $46.6K | $40.7K | |||||
| Liabilities Current | $28.3M | $6.9M | $8.2M | $7.1M | $7.4M | $8.0M | $7.3M | $2.6M | $1.9M | $2.0M | $2.5M | |||||
| Liabilities And Stockholders Equity | $225.9M | $135.9M | $90.9M | $94.3M | $84.1M | $54.8M | $45.4M | $11.9M | $12.8M | $14.6M | $9.5M | |||||
| Liabilities | $129.3M | $107.6M | $45.1M | $43.2M | $42.1M | $40.4M | $32.4M | $3.2M | $2.6M | $2.7M | $3.2M | |||||
| Common Stock Value | $933.8K | $839.1K | $720.7K | $720.7K | $684.1K | $521.3K | $486.0K | $383.5K | $373.9K | $373.9K | $301.1K | |||||
| Assets Current | $174.0M | $101.6M | $59.0M | $65.7M | $56.1M | $32.1M | $26.2M | $2.7M | $4.0M | $5.8M | $1.6M | |||||
| Assets | $225.9M | $135.9M | $90.9M | $94.3M | $84.1M | $54.8M | $45.4M | $11.9M | $12.8M | $14.6M | $9.5M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $949.9K | $29.1K | -$993.6K | -$2.2M | $595.7K | -$701.3K | -$1.5M | -$1.3M | -$1.2M | -$748.8K | $294.5K | |||||
| Accrued Liabilities Current | $3.7M | $1.8M | $3.0M | $2.3M | $1.8M | $2.5M | $1.8M | $1.1M | $807.6K | $408.6K | $977.5K | |||||
| Other Assets Noncurrent | $5.1M | $1.9M | $2.1M | $1.9M | $229.9K | $208.4K | $200.2K | $173.7K | $342.7K | $133.6K | $131.4K | |||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Notes Payable Current | $342.1K | $774.7K | $939.1K | $33.4K | $31.6K | $206.6K | $33.9K | $33.9K | $33.9K | $33.9K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$5.8M | $16.0M | $2.7M | $1.0M | $2.9M | $1.9M | ||||||||||
| Repayments Of Notes Payable | $187.2K | $263.1K | $0.00 | $13.0K | $0.00 | |||||||||||
| Goodwill | $6.8M | $3.4M | $3.3M | $3.2M | $3.5M | $3.3M | $3.3M | $3.3M | ||||||||
| Gain Loss Change In Fair Value Of Share Liability | -$70.9K | -$141.8K | $12.5K | $382.0K | $164.0K | -$218.0K | -$279.4K | $60.1K | ||||||||
| Gain Loss Change In Fair Value Of Convertible Notes Payable | $172.8K | -$63.8M | -$957.4K | -$2.7M | -$1.6M | -$953.7K | $0.00 | $0.00 | ||||||||
| Change In Fair Value Of Share Liability | -$218.0K | -$279.4K | $60.1K | $110.3K | -$2.9K | $0.00 | $0.00 | $0.00 | ||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $364.5K | $0.00 | $952.5K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $9.7M | $2.3M | $4.5M |
| Share Based Compensation | $8.6M | $8.7M | $2.0M |
| Proceeds From Issuance Of Common Stock | $53.1M | $14.1M | $8.1M |
| Increase Decrease In Accounts Payable | -$877.5K | -$224.6K | $570.6K |
| Payments Of Stock Issuance Costs | $3.6M | $563.5K | $1.5M |
| Net Cash Provided By Used In Operating Activities | -$16.7M | -$5.4M | -$2.9M |
| Net Cash Provided By Used In Investing Activities | -$11.4M | -$2.5M | -$4.5M |
| Net Cash Provided By Used In Financing Activities | $82.5M | $13.4M | $6.6M |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$484.0K | -$867.00 | $207.4K |
| Increase Decrease In Other Noncurrent Assets | $9.2K | $59.3K | $146.4K |
| Increase Decrease In Operating Lease Liability | -$427.5K | -$85.8K | -$37.4K |
| Increase Decrease In Accrued Liabilities | $909.9K | $873.7K | $319.0K |
| Proceeds From Convertible Debt | $25.9M | $0.00 | |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payments To Acquire Property Plant And Equipment | $2.3M | $1.2M | $362.1K | $898.9K | $3.0M | $195.7K | |||||||||
| Share Based Compensation | $1.9M | $1.7M | $2.1M | $2.4M | $2.1M | $715.4K | $210.7K | $20.8K | $13.2K | $500.0K | |||||
| Proceeds From Issuance Of Common Stock | $41.0M | $0.00 | $5.0M | $3.8M | $2.4M | $1.7M | $2.1M | ||||||||
| Increase Decrease In Accounts Payable | $1.1M | -$55.0K | -$388.4K | $400.0K | $354.0K | $310.7K | $59.7K | -$24.1K | |||||||
| Payments Of Stock Issuance Costs | $506.4K | $129.2K | $226.0K | ||||||||||||
| Net Cash Provided By Used In Operating Activities | -$3.2M | -$3.0M | -$1.4M | -$287.9K | -$577.7K | -$32.3K | |||||||||
| Net Cash Provided By Used In Investing Activities | -$2.4M | -$1.2M | -$362.1K | -$898.9K | -$3.0M | -$195.7K | |||||||||
| Net Cash Provided By Used In Financing Activities | -$225.1K | $20.3M | $4.5M | $2.2M | $6.5M | $2.1M | |||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$170.2K | -$65.1K | $6.6K | -$229.2K | $18.7K | -$11.1K | |||||||||
| Increase Decrease In Other Noncurrent Assets | -$38.8K | $60.2K | -$34.00 | $0.00 | $0.00 | ||||||||||
| Increase Decrease In Operating Lease Liability | -$60.5K | -$101.7K | -$9.8K | $72.1K | -$72.8K | ||||||||||
| Increase Decrease In Accrued Liabilities | $720.1K | $505.5K | $47.4K | $189.0K | $42.5K | ||||||||||
| Proceeds From Convertible Debt | $0.00 | $5.4M | $20.6M | $0.00 | |||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $4.5M | $4.4M | $1.9M | $2.1M | $2.5M | $1.7M | $2.1M | $2.4M | $2.1M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Common Stock Shares Issued | 48.9M | 35.9M | 20.7M | |
| Common Stock Shares Outstanding | 48.9M | 35.9M | 20.7M | |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | |
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | |
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | |
| Weighted Average Number Of Shares Outstanding Basic | 55.7M | 33.1M | 26.8M | |
| Earnings Per Share Basic | $-0.63 | $-0.49 | $-0.18 | |
| Weighted Average Number Of Diluted Shares Outstanding | 55.7M | 33.1M | ||
| Earnings Per Share Diluted | $-0.63 | $-0.49 | ||
| Weighted Average Shares Of Common Stock Outstanding Basic And Diluted | 33.1M | 26.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Shares Issued | 93.4M | 83.9M | 72.1M | 72.1M | 68.4M | 52.1M | 48.6M | 38.3M | 37.4M | 37.4M | 30.1M | ||||
| Common Stock Shares Outstanding | 93.4M | 83.9M | 72.1M | 72.1M | 68.4M | 52.1M | 48.6M | 38.3M | 37.4M | 37.4M | 30.1M | ||||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 50.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||
| Preferred Stock Par Or Stated Value Per Share | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | |||||
| Weighted Average Number Of Shares Outstanding Basic | 88.6M | 73.0M | 69.5M | 61.5M | 49.1M | 44.6M | 31.1M | 30.1M | 16.2M | 2.8M | |||||
| Earnings Per Share Basic | $-0.15 | $-1.03 | $-0.12 | $-0.12 | $-0.24 | $-0.16 | $-0.14 | $-0.06 | $-0.16 | $-0.18 | |||||
| Weighted Average Number Of Diluted Shares Outstanding | 88.6M | 73.0M | 69.5M | 61.5M | 49.1M | 44.6M | 31.1M | 30.1M | 2.8M | ||||||
| Earnings Per Share Diluted | $-0.15 | $-1.03 | $-0.12 | $-0.12 | $-0.24 | $-0.16 | $-0.14 | $-0.06 | $-0.18 | ||||||
| Weighted Average Shares Of Common Stock Outstanding Basic And Diluted | 49.1M | 44.6M | 31.1M | 29.8M | 29.1M | 30.1M | 27.1M | 26.4M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | $69.9K | $45.8K | ||
| Interest Income Other | $1.2M | $9.1K | $3.4K | |
| Additional Paid In Capital | $40.6M | $16.8M | $8.4M | |
| Other Noncash Income Expense | -$621.9K | $0.00 | ||
| Fair Value Of Shares Issuable | 140.5K | 116.2K | ||
| Depreciation | $471.4K | $37.4K | $0.00 | |
| Net Loss Attributable To Asp Isotopes Inc Shareholders | -$35.1M | -$16.3M | ||
| Income Loss Attributable To Noncontrolling Interest | -$89.1K | -$7.9K | ||
| Distribution To Noncontrolling Interest Of Variable Interest Entity | -$97.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Foreign Currency Transaction Gain Loss Before Tax | -$41.9K | -$37.0K | -$61.5K | -$131.2K | $26.1K | -$24.3K | $0.00 | $0.00 | -$935.00 | $0.00 | $0.00 | $0.00 | ||
| Interest Income Other | $1.8M | $925.0K | $513.7K | $602.2K | $43.5K | $12.2K | $3.5K | $1.1K | $396.00 | $453.00 | ||||
| Additional Paid In Capital | $224.7M | $164.0M | $107.4M | $105.5M | $84.4M | $50.9M | $42.3M | $29.2M | $26.5M | $23.5M | $12.0M | |||
| Other Noncash Income Expense | $0.00 | $108.2K | $513.7K | $0.00 | ||||||||||
| Fair Value Of Shares Issuable | 220.6K | 149.8K | 234.5K | 0.00 | 416.7K | 306.0K | 413.0K | 0.00 | 142.5K | 390.8K | 220.8K | 243.9K | ||
| Depreciation | $149.0K | $103.2K | $802.00 | $167.00 | $0.00 | $0.00 | $0.00 | |||||||
| Net Loss Attributable To Asp Isotopes Inc Shareholders | -$12.9M | -$75.1M | -$8.4M | -$7.3M | -$11.7M | -$6.9M | -$4.2M | -$4.3M | ||||||
| Income Loss Attributable To Noncontrolling Interest | -$19.6K | -$94.3K | -$15.2K | -$84.2K | $51.5K | -$16.8K | $0.00 | $0.00 | ||||||
| Distribution To Noncontrolling Interest Of Variable Interest Entity | -$324.4K | -$41.0K | -$38.3K | -$33.2K | -$18.4K | -$8.7K |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.